Johnson Johnson (JNJ)

Healthcare | Drug Manufacturers General
Income Statement (Quarterly) 2025-03-30 2024-12-29 2024-09-29 2024-09-28
Revenue 21,893,000,000 22,520,000,000 22,471,000,000 22,471,000,000
Cost of Revenue 7,357,000,000 7,128,000,000 6,963,000,000 6,783,000,000
Gross Profit 14,536,000,000 15,392,000,000 15,508,000,000 15,688,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 5,012,000,000 6,253,000,000 5,278,000,000 5,475,000,000
Operating Expenses 8,237,000,000 11,551,000,000 10,230,000,000 10,427,000,000
Operating Income 6,299,000,000 3,841,000,000 5,278,000,000 5,261,000,000
Interest Expense 204,000,000 137,000,000 193,000,000 0
Income Before Tax 13,631,000,000 3,887,000,000 3,338,000,000 3,338,000,000
Income Tax Expense 2,632,000,000 456,000,000 644,000,000 644,000,000
Net Income 10,999,000,000 3,431,000,000 2,694,000,000 2,694,000,000
Per Share
EPS 4.57 1.43 1.12 1.11
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-29 2023-12-31 2023-01-01 2022-01-02 2021-01-03
Revenue 88,821,000,000 85,159,000,000 94,943,000,000 93,775,000,000 82,584,000,000
Cost of Revenue 27,471,000,000 26,553,000,000 31,089,000,000 29,855,000,000 28,427,000,000
Gross Profit 61,350,000,000 58,606,000,000 63,854,000,000 63,920,000,000 54,157,000,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 21,969,000,000 20,112,000,000 24,765,000,000 24,659,000,000 22,084,000,000
Operating Expenses 39,201,000,000 35,197,000,000 40,151,000,000 39,373,000,000 34,243,000,000
Operating Income 22,149,000,000 23,409,000,000 23,917,000,000 24,547,000,000 19,914,000,000
Interest Expense 755,000,000 772,000,000 276,000,000 183,000,000 201,000,000
Income Before Tax 16,687,000,000 15,062,000,000 21,725,000,000 22,776,000,000 16,497,000,000
Income Tax Expense 2,621,000,000 1,736,000,000 3,784,000,000 1,898,000,000 1,783,000,000
Net Income 14,066,000,000 35,153,000,000 17,941,000,000 20,878,000,000 14,714,000,000
Per Share
EPS 5.84 13.88 6.83 7.93 5.59
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-29 2023-12-31 2023-01-01 2022-12-31
Assets
Cash and Cash Equivalents 24,105,000,000 21,859,000,000 14,127,000,000 14,127,000,000
Short Term Investments 417,000,000 1,068,000,000 9,392,000,000 9,392,000,000
Net Receivables 18,927,000,000 19,387,000,000 16,160,000,000 19,292,000,000
Inventory 12,444,000,000 11,181,000,000 12,483,000,000 12,483,000,000
Total Current Assets 55,893,000,000 53,495,000,000 55,294,000,000 55,294,000,000
Property Plant Equipment 20,518,000,000 19,898,000,000 19,803,000,000 19,803,000,000
Goodwill and Intangibles 81,818,000,000 70,733,000,000 93,556,000,000 93,556,000,000
Total Assets 180,104,000,000 167,558,000,000 187,378,000,000 187,378,000,000
Liabilities
Account Payables 10,311,000,000 9,632,000,000 11,703,000,000 11,703,000,000
Short Term Debt 5,983,000,000 3,451,000,000 12,771,000,000 12,771,000,000
Total Current Liabilities 50,321,000,000 46,282,000,000 55,802,000,000 55,802,000,000
Long Term Debt 30,651,000,000 25,881,000,000 26,888,000,000 26,888,000,000
Total Liabilities 108,614,000,000 98,784,000,000 110,574,000,000 110,574,000,000
Shareholders Equity
Retained Earnings 155,791,000,000 153,843,000,000 128,345,000,000 128,345,000,000
Total Shareholders Equity 71,490,000,000 68,774,000,000 76,804,000,000 76,804,000,000
Balance Sheet (Annual) 2024-12-29 2023-12-31 2023-01-01 2022-12-31 2022-01-02
Assets
Cash and Cash Equivalents 24,105,000,000 21,859,000,000 14,127,000,000 14,127,000,000 14,487,000,000
Short Term Investments 417,000,000 1,068,000,000 9,392,000,000 9,392,000,000 17,121,000,000
Net Receivables 18,927,000,000 19,387,000,000 16,160,000,000 19,292,000,000 15,283,000,000
Inventory 12,444,000,000 11,181,000,000 12,483,000,000 12,483,000,000 10,387,000,000
Total Current Assets 55,893,000,000 53,495,000,000 55,294,000,000 55,294,000,000 60,979,000,000
Property Plant Equipment 20,518,000,000 19,898,000,000 19,803,000,000 19,803,000,000 18,962,000,000
Goodwill and Intangibles 81,818,000,000 70,733,000,000 93,556,000,000 93,556,000,000 81,638,000,000
Total Assets 180,104,000,000 167,558,000,000 187,378,000,000 187,378,000,000 182,018,000,000
Liabilities
Account Payables 10,311,000,000 9,632,000,000 11,703,000,000 11,703,000,000 11,055,000,000
Short Term Debt 5,983,000,000 3,451,000,000 12,771,000,000 12,771,000,000 3,766,000,000
Total Current Liabilities 50,321,000,000 46,282,000,000 55,802,000,000 55,802,000,000 45,226,000,000
Long Term Debt 30,651,000,000 25,881,000,000 26,888,000,000 26,888,000,000 29,985,000,000
Total Liabilities 108,614,000,000 98,784,000,000 110,574,000,000 110,574,000,000 107,995,000,000
Shareholders Equity
Retained Earnings 155,791,000,000 153,843,000,000 128,345,000,000 128,345,000,000 123,060,000,000
Total Shareholders Equity 71,490,000,000 68,774,000,000 76,804,000,000 76,804,000,000 74,023,000,000
Cash Flow Statement (Quarterly) 2024-12-29 2023-12-31 2023-01-01 2022-12-31
Operating Activities
Net Income 14,066,000,000 13,326,000,000 17,941,000,000 17,941,000,000
Depreciation & Amortization 7,339,000,000 7,486,000,000 6,970,000,000 6,970,000,000
Stock Based Compensation 1,176,000,000 1,162,000,000 1,138,000,000 1,138,000,000
Change in Working Capital 1,837,000,000 2,507,000,000 -4,011,000,000 -4,011,000,000
Operating Cash Flow 24,266,000,000 22,791,000,000 21,194,000,000 21,194,000,000
Investing Activities
Capital Expenditure -4,424,000,000 -4,543,000,000 -4,009,000,000 -4,009,000,000
Investments -4,424,000,000 -4,543,000,000 -4,009,000,000 -4,009,000,000
Investing Cash Flow -18,599,000,000 878,000,000 -12,371,000,000 -12,371,000,000
Financing Activities
Debt Repayment 10,051,000,000 -10,781,000,000 -8,684,000,000 -8,684,000,000
Common Stock Issued/Repurchased -2,432,000,000 8,328,000,000 -4,706,000,000 -6,035,000,000
Dividends Paid -11,823,000,000 -11,770,000,000 -11,682,000,000 -11,682,000,000
Financing Cash Flow -3,132,000,000 -15,825,000,000 -8,871,000,000 -8,871,000,000
Summary
Free Cash Flow 19,842,000,000 18,248,000,000 17,185,000,000 17,185,000,000
Net Change in Cash 2,246,000,000 8,970,000,000 -360,000,000 -360,000,000
Cash Flow Statement (Annual) 2024-12-29 2023-12-31 2023-01-01 2022-12-31 2022-01-02
Operating Activities
Net Income 14,066,000,000 13,326,000,000 17,941,000,000 17,941,000,000 20,878,000,000
Depreciation & Amortization 7,339,000,000 7,486,000,000 6,970,000,000 6,970,000,000 7,390,000,000
Stock Based Compensation 1,176,000,000 1,162,000,000 1,138,000,000 1,138,000,000 1,135,000,000
Change in Working Capital 1,837,000,000 2,507,000,000 -4,011,000,000 -4,011,000,000 -4,238,000,000
Operating Cash Flow 24,266,000,000 22,791,000,000 21,194,000,000 21,194,000,000 23,410,000,000
Investing Activities
Capital Expenditure -4,424,000,000 -4,543,000,000 -4,009,000,000 -4,009,000,000 -3,652,000,000
Investments -4,424,000,000 -4,543,000,000 -4,009,000,000 -4,009,000,000 -3,652,000,000
Investing Cash Flow -18,599,000,000 878,000,000 -12,371,000,000 -12,371,000,000 -8,683,000,000
Financing Activities
Debt Repayment 10,051,000,000 -10,781,000,000 -8,684,000,000 -8,684,000,000 -2,992,000,000
Common Stock Issued/Repurchased -2,432,000,000 8,328,000,000 -4,706,000,000 -6,035,000,000 -3,456,000,000
Dividends Paid -11,823,000,000 -11,770,000,000 -11,682,000,000 -11,682,000,000 -11,032,000,000
Financing Cash Flow -3,132,000,000 -15,825,000,000 -8,871,000,000 -8,871,000,000 -14,047,000,000
Summary
Free Cash Flow 19,842,000,000 18,248,000,000 17,185,000,000 17,185,000,000 19,758,000,000
Net Change in Cash 2,246,000,000 8,970,000,000 -360,000,000 -360,000,000 502,000,000